1 |
AlMalki WH, Shahid I, Abdalla AN, Johargy AK, Ahmed M, Hassan S. Virological surveillance, molecular phylogeny, and evolutionary dynamics of hepatitis C virus subtypes 1a and 4a isolates in patients from Saudi Arabia. Saudi J Biol Sci 2021;28:1664-77. [PMID: 33732052 DOI: 10.1016/j.sjbs.2020.11.089] [Reference Citation Analysis]
|
2 |
Ndeboko B, Omouessi ST, Ongali B, Mouinga-Ondémé A. Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B Virus. Pharmaceuticals (Basel) 2020;13:483. [PMID: 33371278 DOI: 10.3390/ph13120483] [Reference Citation Analysis]
|
3 |
Balakrishnan KN, Abdullah AA, Bala JA, Jesse FFA, Abdullah CAC, Noordin MM, Mohd-Azmi ML. Immediately early 2 (IE-2) and DNA polymerase SiRNA as virus-specific antiviral against novel transplacental cytomegalovirus strain ALL-03 in vitro. Infect Genet Evol 2021;90:104783. [PMID: 33640483 DOI: 10.1016/j.meegid.2021.104783] [Reference Citation Analysis]
|
4 |
AlMalki WH, Shahid I, Abdalla AN, Johargy AK, Ahmed M, Hassan S. Consensus small interfering RNA targeted to stem-loops II and III of IRES structure of 5' UTR effectively inhibits virus replication and translation of HCV sub-genotype 4a isolates from Saudi Arabia. Saudi J Biol Sci 2021;28:1109-22. [PMID: 33424405 DOI: 10.1016/j.sjbs.2020.11.041] [Reference Citation Analysis]
|